Axsome
is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders... Read moreAxsome
is a New York-based biopharmaceutical company that researches and develops novel therapies for the treatment of central nervous system disorders... Read more
News
Mar 26, 2025
BioCentury
Axsome: Axsome's latest win comes in ADHD, Opthea seeks path after AMD miss, and more: Clinical Report
Mar 26, 2025
Zacks
Axsome: AXSM Stock Down Despite ADHD Study Meeting Primary Endpoint
Mar 25, 2025
Endpoints News
Axsome: Axsome reports Phase 3 win for Sunosi in adults with ADHD
Mar 25, 2025
Investors Business Daily
Axsome: IBD 50's Axsome Therapeutics Dives On Mixed ADHD Results. Why Analysts Aren't Worried.
Mar 25, 2025
Benzinga
Axsome: Axsome Therapeutics Lower Dose Of Attention Deficient Disorder Candidate Hits Primary Goal
Mar 07, 2025
Drug Store News
Axsome: Axsome Therapeutics settles Sunosi patent litigation with Hikma
Mar 04, 2025
Zacks
Axsome: AXSM Gets Positive FDA Feedback for Alzheimer's Agitation Drug Filing
Mar 03, 2025
GlobalNewswire
Press Release: Axsome : Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer's Disease Agitation Supporting NDA Submission
Feb 24, 2025
Benzinga
Axsome: Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs
Feb 20, 2025
Drug Store News
Axsome: Axsome, Teva settle litigation over Auvelity
Axsome Competitors
1
2
3
4
5
6
7
8
9
10